Diagnosing Balamuthia mandrillaris Encephalitis With Metagenomic Deep Sequencing

Michael R Wilson, Niraj M Shanbhag, Michael J Reid, Neel S Singhal, Jeffrey M Gelfand, Hannah A Sample, Barlas Benkli, Brian D O'Donovan, Ibne K M Ali, M Kelly Keating, Thelma H Dunnebacke, Matthew D Wood, Andrew Bollen, Joseph L DeRisi, Michael R Wilson, Niraj M Shanbhag, Michael J Reid, Neel S Singhal, Jeffrey M Gelfand, Hannah A Sample, Barlas Benkli, Brian D O'Donovan, Ibne K M Ali, M Kelly Keating, Thelma H Dunnebacke, Matthew D Wood, Andrew Bollen, Joseph L DeRisi

Abstract

Objective: Identification of a particular cause of meningoencephalitis can be challenging owing to the myriad bacteria, viruses, fungi, and parasites that can produce overlapping clinical phenotypes, frequently delaying diagnosis and therapy. Metagenomic deep sequencing (MDS) approaches to infectious disease diagnostics are known for their ability to identify unusual or novel viruses and thus are well suited for investigating possible etiologies of meningoencephalitis.

Methods: We present the case of a 74-year-old woman with endophthalmitis followed by meningoencephalitis. MDS of her cerebrospinal fluid (CSF) was performed to identify an infectious agent.

Results: Sequences aligning to Balamuthia mandrillaris ribosomal RNA genes were identified in the CSF by MDS. Polymerase chain reaction subsequently confirmed the presence of B. mandrillaris in CSF, brain tissue, and vitreous fluid from the patient's infected eye. B. mandrillaris serology and immunohistochemistry for free-living amoebas on the brain biopsy tissue were positive.

Interpretation: The diagnosis was made using MDS after the patient had been hospitalized for several weeks and subjected to costly and invasive testing. MDS is a powerful diagnostic tool with the potential for rapid and unbiased pathogen identification leading to early therapeutic targeting.

© 2015 The Authors Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association.

Figures

Figure 1
Figure 1
Neuroimaging and neuropathology. (A) Axial T2‐weighted/fluid‐attenuated inversion recovery (FLAIR) brain magnetic resonance imaging (MRI) demonstrating multiple hyperintensities (arrows), which correspond to areas of restricted diffusion on diffusion weighted imaging (not shown). (B) Axial T2‐weighted/FLAIR brain MRI demonstrating progression in the size and number of hyperintensities (arrows) visualized in the MRI in (A). (C) Postcontrast axial T1‐weighted brain MRI demonstrating multiple ring enhancing lesions (white arrow) and basilar meningitis (yellow arrow) as well as severe hydrocephalus. (D) Periodic acid‐Schiff stained section of brain parenchyma shows necrotizing vasculitis, chronic inflammatory cells, and a population of amoebic trophozoites that closely resemble macrophages (arrows); 400×. The majority of the tissue showed a robust necrotizing vasculitis with mixed inflammation, including macrophages and numerous eosinophils. (E) Immunohistochemistry for free‐living amoebas highlights numerous B. mandrillaris trophozoites; 400 × (courtesy of M.K.K., CDC).

References

    1. Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next‐generation sequencing. N Engl J Med 2014;370:2408–2417.
    1. Vora NM, Holman RC, Mehal JM, et al. Burden of encephalitis‐associated hospitalizations in the United States, 1998–2010. Neurology 2014;82:443–451.
    1. Ruby JG, Bellare P, Derisi JL. PRICE: software for the targeted assembly of components of (Meta) genomic sequence data. G3 (Bethesda) 2013;3:865–880.
    1. Langmead B, Salzberg SL. Fast gapped‐read alignment with Bowtie 2. Nature Methods 2012;9:357–359.
    1. Fu L, Niu B, Zhu Z, Wu S, Li W. CD‐HIT: accelerated for clustering the next‐generation sequencing data. Bioinformatics 2012;28:3150–3152.
    1. Li W, Godzik A. Cd‐hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 2006;22:1658–1659.
    1. Wu TD, Nacu S. Fast and SNP‐tolerant detection of complex variants and splicing in short reads. Bioinformatics 2010;26:873–881.
    1. Qvarnstrom Y, Visvesvara GS, Sriram R, da Silva AJ. Multiplex real‐time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri . J Clin Microbiol 2006;44:3589–3595.
    1. Schuster FL, Yagi S, Wilkins PP, et al. Balamuthia mandrillaris, agent of amebic encephalitis: detection of serum antibodies and antigenic similarity of isolates by enzyme immunoassay. J Eukaryot Microbiol 2008;55:313–320.
    1. Lorenzo‐Morales J, Cabello‐Vilchez AM, Martin‐Navarro CM, et al. Is Balamuthia mandrillaris a public health concern worldwide? Trends Parasitol 2013;29:483–488.
    1. Visvesvara GS, Martinez AJ, Schuster FL, et al. Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals. J Clin Microbiol 1990;28:2750–2756.
    1. Schuster FL, Glaser C, Honarmand S, Maguire JH, Visvesvara GS. Balamuthia amebic encephalitis risk, Hispanic Americans. Emerg Infect Dis 2004;10:1510–1512.
    1. Griesemer DA, Barton LL, Reese CM, et al. Amebic meningoencephalitis caused by Balamuthia mandrillaris . Pediatr Neurol 1994;10:249–254.
    1. Rowen JL, Doerr CA, Vogel H, Baker CJ. Balamuthia mandrillaris: a newly recognized agent for amebic meningoencephalitis. Pediatr Infect Dis J 1995;14:705–710.
    1. Denney CF, Iragui VJ, Uber‐Zak LD, et al. Amebic meningoencephalitis caused by Balamuthia mandrillaris: case report and review. Clin Infect Dis 1997;25:1354–1358.
    1. Reed RP, Cooke‐Yarborough CM, Jaquiery AL, et al. Fatal granulomatous amoebic encephalitis caused by Balamuthia mandrillaris . Med J Aust 1997;167:82–84.
    1. Schuster FL, Yagi S, Gavali S, et al. Under the radar: balamuthia amebic encephalitis. Clin Infect Dis 2009;48:879–887.
    1. Guarner J, Bartlett J, Shieh WJ, et al. Histopathologic spectrum and immunohistochemical diagnosis of amebic meningoencephalitis. Mod Pathol 2007;20:1230–1237.
    1. Schuster FL, Visvesvara GS. Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals. J Clin Microbiol 1996;34:385–388.
    1. Deetz TR, Sawyer MH, Billman G, Schuster FL, Visvesvara GS. Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Clin Infect Dis 2003;37:1304–1312.
    1. Martinez DY, Seas C, Bravo F, et al. Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement. Clin Infect Dis 2010;51:e7–e11.
    1. Jung S, Schelper RL, Visvesvara GS, Chang HT. Balamuthia mandrillaris. meningoencephalitis in an immunocompetent patient: an unusual clinical course and a favorable outcome. Arch Pathol Lab Med 2004;128:466–468.
    1. Kodet R, Nohynkova E, Tichy M, Soukup J, Visvesvara GS. Amebic encephalitis caused by Balamuthia mandrillaris in a Czech child: description of the first case from Europe. Pathol Res Pract 1998;194:423–429.
    1. Schuster FL. Cultivation of pathogenic and opportunistic free‐living amebas. Clin Microbiol Rev 2002;15:342–354.

Source: PubMed

3
Suscribir